Email updates

Keep up to date with the latest news and content from BMC International Health and Human Rights and BioMed Central.

Open Access Case report

Evaluating Niger's experience in strengthening supervision, improving availability of child survival drugs through cost recovery, and initiating training for Integrated Management of Childhood Illness (IMCI)

Youssef M Tawfik1*, Stephane Legros2 and Colette Geslin3

Author affiliations

1 Senior Child Survival Advisor, Support for Analysis and Research in Africa (SARA) Project, Academy for Educational Development, 1875 Connecticut Avenue, NW, Washington DC, 20009 USA

2 Senior Quality Assurance Advisor, Quality Assurance Project, Bethesda Maryland, USA

3 Country Representative, BASICS, Niger

For all author emails, please log on.

Citation and License

BMC International Health and Human Rights 2001, 1:1  doi:10.1186/1472-698X-1-1

Published: 23 July 2001



WHO and UNICEF have recently developed the "Integrated Management of Childhood Illness" (IMCI) as an efficient strategy to assist developing countries reduce childhood mortality. Early experience with IMCI implementation suggests that clinical training is essential but not sufficient for the success of the strategy. Attention needs to be given to strengthening health systems, such as supervision and drug supply.


This paper presents results of evaluating an innovative approach for implementing IMCI in Niger. It starts with strengthening district level supervision and improving the availability of child survival drugs through cost recovery well before the beginning of IMCI clinical training. The evaluation documented the effectiveness of the initial IMCI clinical training and referral.


Strengthening supervision and assuring the availability of essential drugs need to precede the initiation of IMCI Clinical training. Longer term follow up is necessary to confirm the impact of the approach on IMCI preparation and implementation.